Takara Bio Inc. (TYO:4974)
Japan
· Delayed Price · Currency is JPY 867.00
-15.00 (-1.70%)
Feb 27, 2025, 3:30 PM JST
Takara Bio Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | -52 | 2,853 | 21,224 | 27,532 | 13,552 | 5,433 | Upgrade
|
| Depreciation & Amortization | 4,593 | 5,021 | 4,735 | 4,149 | 3,786 | 3,530 | Upgrade
|
| Loss (Gain) From Sale of Assets | 353 | 551 | 97 | 336 | 97 | 911 | Upgrade
|
| Asset Writedown & Restructuring Costs | 240 | - | - | - | - | - | Upgrade
|
| Other Operating Activities | 940 | -2,812 | -9,245 | -5,240 | -1,675 | -1,249 | Upgrade
|
| Change in Accounts Receivable | 301 | 1,501 | 5,718 | -4,812 | -3,559 | -579 | Upgrade
|
| Change in Inventory | -1,158 | -324 | 13,510 | -14,233 | -1,767 | -974 | Upgrade
|
| Change in Accounts Payable | -632 | -4,367 | 139 | -431 | 1,016 | -468 | Upgrade
|
| Change in Other Net Operating Assets | 1,527 | -712 | 719 | -316 | 2,493 | -265 | Upgrade
|
| Operating Cash Flow | 6,112 | 1,711 | 36,897 | 6,985 | 13,943 | 6,339 | Upgrade
|
| Operating Cash Flow Growth | -74.66% | -95.36% | 428.23% | -49.90% | 119.96% | 9.61% | Upgrade
|
| Capital Expenditures | -10,212 | -12,778 | -5,747 | -12,403 | -8,687 | -3,983 | Upgrade
|
| Sale of Property, Plant & Equipment | 4 | 9 | 396 | 47 | 14 | 110 | Upgrade
|
| Investment in Securities | -760 | 713 | -1,215 | 1,471 | 3,153 | 3,730 | Upgrade
|
| Other Investing Activities | -13 | -987 | -127 | 3,814 | 1,742 | -69 | Upgrade
|
| Investing Cash Flow | -10,981 | -13,043 | -6,693 | -7,071 | -3,778 | -212 | Upgrade
|
| Total Debt Repaid | -205 | - | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -205 | - | - | - | - | - | Upgrade
|
| Common Dividends Paid | -2,051 | - | - | - | - | - | Upgrade
|
| Dividends Paid | -2,051 | -5,052 | -3,968 | -1,923 | -962 | -841 | Upgrade
|
| Other Financing Activities | - | -181 | -151 | -147 | -141 | -105 | Upgrade
|
| Financing Cash Flow | -2,256 | -5,233 | -4,119 | -2,070 | -1,103 | -946 | Upgrade
|
| Foreign Exchange Rate Adjustments | -273 | 678 | 813 | 1,008 | -215 | -182 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 2 | 1 | -1 | - | -2 | -1 | Upgrade
|
| Net Cash Flow | -7,396 | -15,886 | 26,897 | -1,148 | 8,845 | 4,998 | Upgrade
|
| Free Cash Flow | -4,100 | -11,067 | 31,150 | -5,418 | 5,256 | 2,356 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 123.09% | - | Upgrade
|
| Free Cash Flow Margin | -9.52% | -25.44% | 39.86% | -8.00% | 11.40% | 6.82% | Upgrade
|
| Free Cash Flow Per Share | -34.05 | -91.91 | 258.69 | -44.99 | 43.65 | 19.57 | Upgrade
|
| Cash Interest Paid | 21 | 22 | 24 | 23 | 24 | 7 | Upgrade
|
| Cash Income Tax Paid | - | 2,359 | 9,902 | 5,922 | 1,854 | 1,247 | Upgrade
|
| Levered Free Cash Flow | - | -14,752 | 27,578 | -7,401 | 5,743 | 1,683 | Upgrade
|
| Unlevered Free Cash Flow | - | -14,737 | 27,593 | -7,386 | 5,758 | 1,688 | Upgrade
|
| Change in Net Working Capital | -1,468 | 8,857 | -15,767 | 17,196 | -1,938 | 1,782 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.